Zuvekas Samuel H, Meyerhoefer Chad D
Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD 20850, USA.
J Ment Health Policy Econ. 2006 Sep;9(3):155-63.
Consumers have long faced high out-of-pocket costs for mental health and substance abuse treatment in private health insurance plans, the predominant form of insurance coverage in the United States. Nominal mental health benefits may have improved from the mid-1990s onwards, as many states passed mental health parity mandates and other employers voluntarily improved coverage. However, the rapid rise of managed behavioral health care organizations (MBHOs) may have effectively offset these gains in nominal coverage.
We examine how effective mental health benefits, as measured by actual out-of-pocket expenses, compares to coverage for non-mental health treatment and how this has changed in recent years.
We used detailed data on health care use and expenses from the nationally representative, Medical Expenditure Panel Survey (MEPS) to describe the distribution of out-of-pocket expenses for mental health and non-mental health ambulatory visits and prescription drug fills and demonstrate how this changed between 1996 and 2003. In addition, we use two-limit tobit regression models to descriptively examine the factors associated with higher out-of-pocket costs for ambulatory mental health treatment.
While out-of-pockets shares generally decreased over the 1996-2003 period, from 39 to 35 percent of total expenses for ambulatory mental health visits and from 31 to 26 percent for non-mental health ambulatory visits, the ratio of out-of-pockets costs is still significantly higher for mental health care. Out-of-pocket expenses per visit fell as the number of non-mental health visits increased but out-of-pocket expenses for mental health visits rose with more visits. Out-of-pocket expenses for visits to specialty mental health providers were substantially higher than for non-psychiatrist physicians. Though prescription drug spending increased substantially, the percent paid out-of-pocket did not change for mental health and non-mental health related fills.
Our results suggest that expenses for ambulatory mental health visits, especially for specialty providers, effectively remain less well covered than other medical visits.
Continued high out-of-pocket expenses for mental health treatment may impede access to mental health treatment, especially for those who need greater treatment intensity.
Mental health parity may not ensure that coverage for mental health services is, in actuality, equal.
Additional research is needed in understanding relative changes in nominal vs. actual or effective coverage.
在美国,私人医疗保险计划是主要的保险形式,长期以来,消费者在心理健康和药物滥用治疗方面面临高额自付费用。自20世纪90年代中期以来,名义上的心理健康福利可能有所改善,因为许多州通过了心理健康平权法案,其他雇主也自愿提高了保险范围。然而,管理式行为健康护理组织(MBHOs)的迅速崛起可能有效地抵消了名义保险范围的这些改善。
我们研究以实际自付费用衡量的心理健康福利与非心理健康治疗的保险范围相比有多有效,以及近年来这一情况如何变化。
我们使用了具有全国代表性的医疗支出面板调查(MEPS)中关于医疗保健使用和费用的详细数据,来描述心理健康和非心理健康门诊就诊及处方药配药的自付费用分布,并展示1996年至2003年期间的变化情况。此外,我们使用双限托比特回归模型来描述性地研究与门诊心理健康治疗较高自付费用相关的因素。
虽然在1996 - 2003年期间自付费用比例总体上有所下降,心理健康门诊就诊的自付费用占总费用的比例从39%降至35%,非心理健康门诊就诊的比例从31%降至26%,但心理健康护理的自付费用比例仍然显著更高。每次就诊的自付费用随着非心理健康就诊次数的增加而下降,但心理健康就诊的自付费用随着就诊次数的增加而上升。专科心理健康提供者就诊的自付费用大大高于非精神科医生就诊的费用。尽管处方药支出大幅增加,但心理健康和非心理健康相关配药的自付比例没有变化。
我们的结果表明,门诊心理健康就诊的费用,特别是专科提供者的费用,实际上仍然比其他医疗就诊的保险覆盖程度低。
心理健康治疗持续高昂的自付费用可能会阻碍人们获得心理健康治疗,尤其是对于那些需要更高治疗强度的人。
心理健康平权可能无法确保心理健康服务的实际覆盖是平等的。
需要更多研究来理解名义保险范围与实际或有效保险范围的相对变化。